• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC. (JUAREZ) THERMOCOOL® SF NAV UNI-DIRECTIONAL CATHETER; SIMILAR DEVICE D131801, PMA # P030031/S034

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC. (JUAREZ) THERMOCOOL® SF NAV UNI-DIRECTIONAL CATHETER; SIMILAR DEVICE D131801, PMA # P030031/S034 Back to Search Results
Model Number D-1318-00
Device Problem Insufficient Information (3190)
Patient Problems Fistula (1862); Transient Ischemic Attack (2109); Cardiac Tamponade (2226); Pseudoaneurysm (2605)
Event Date 05/01/2014
Event Type  Injury  
Event Description
Article title: enhanced efficiency of a novel porous tip irrigated rf ablation catheter for pulmonary vein isolation per a report in the journal of j cardiovasc electrophysiol 2013;24:1328-1335.A prospective randomized study was conducted on 160 patients, by (b)(6) of (b)(6) to compare the efficiency and the safety of 2 different open irrigated tip rf ablation catheters.Mean follow-up time: 20.5 ±7.5 months.From the report there were 4 serious adverse events: 1 patient in the sf group had a tia 2 days after ablation, 1 patient in the thermocool group developed cardiac tamponade requiring urgent thoracotomy.Two (2) patients in the sf group developed femoral puncture-related complications (arterio-venous fistula or pseudoaneurysm) requiring surgery.Per the article, other non-serious ae¿s were also reported: 2 patients in the sf group (arterio-venous fistula or pseudoaneurysm) and 3 in the thermocool group (arterio-venous fistula) developed femoral puncture-related complications and were all treated conservatively.These events are not known to have required extended hospitalization stay.If additional information is received, we will update information in a supplemental report.There are no death events and no device malfunctions reported in the publication.Model and catalog number are not available, but the suspected device are the thermocool sf and the navistar thermocool.This report covers the serious injuries reported with thermocool sf: 1 tia 2 days after ablation, 2 femoral puncture-related complications (arterio-venous fistula or pseudoaneurysm) requiring surgery.
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SF NAV UNI-DIRECTIONAL CATHETER
Type of Device
SIMILAR DEVICE D131801, PMA # P030031/S034
Manufacturer (Section D)
BIOSENSE WEBSTER, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvacar
juarez, chihuahua 32599
MX  32599
Manufacturer (Section G)
BIOSENSE WEBSTER, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvacar
juarez, chihuahua 3259 9
MX   32599
Manufacturer Contact
jaime chavez
15715 arrow highway
irwindale, CA 91706
9098398483
MDR Report Key4146531
MDR Text Key4772121
Report Number9673241-2014-00398
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Other
Type of Report Initial
Report Date 09/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-1318-00
Device Catalogue NumberD131800
Device Lot NumberUNKNOWN_D-1318-00-S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/17/2014
Initial Date FDA Received10/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age61 YR
-
-